HopeStage
Back to all studies
RecruitingNCT05295888

Pilot study of temporal-interference brain stimulation for depression

About this titleRead the official source — NCT05295888
Device studyAges 18–65Canada
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Listed locations
TorontoSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: May 15, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
30
Sponsor
Unity Health Toronto
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
Canada
Age range
From 18 Years to 65 Years
Official registry ID
NCT05295888
Official title
Show the full official title

Evaluation of Temporal Interference in Target Engagement of Subgenual Cingulate Cortex in the Treatment of Major Depressive Disorder

Recruitment & locations

Currently recruiting

Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Unity Health Toronto.

Who can participate?

This study is for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies